-20℃ 3 years powder
-80℃ 2 years in solvent
Cenobamate, a sodium channel blocker, enhances GABAergic transmission. It has the potential to be a versatile CNS drug.
Pack Size | Availability | Price/USD | Quantity |
---|
Description | Cenobamate, a sodium channel blocker, enhances GABAergic transmission. It has the potential to be a versatile CNS drug. |
Targets&IC50 | Sodium channel, GABA receptor, |
In vivo | Cenobamate (YKP3089) is effective in reducing significantly the expression of stage 5 seizures in the hippocampal kindled rat (ED50: 16.4 mg/kg) and it also is effective in the mouse 6 Hz psychomotor seizure model at 22, 32 and 44 mA with ED50 values of 11.0, 17.9 and 16.5 mg/kg, respectively. Cenobamate is also effective against seizure-induced by picrotoxin (ED50: 34.5 mg/kg) in mice. Cenobamate protects against MES induced seizures in mice (ED50: 9.8 mg/kg i.p.) and in rats (ED50: 1.9 mg/kg p.o.) and it also protects against lithium pilocarpine-induced intractable seizures in rats (i.p., ED50: 7.0 mg/kg). Cenobamate given i.p inhibited the clonic seizures in mice and rats (ED50: 28.5 and 13.6 mg/kg), in the sc Met seizures model [2]. |
Synonyms | YKP3089 |
Purity | 98.00% |
Molecular Weight | 267.67 |
Formula | C10H10ClN5O2 |
CAS No. | 913088-80-9 |
-20℃ 3 years powder
-80℃ 2 years in solvent
DMSO: 126 mg/mL (470.73 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.